Insider cluster shows 2 insiders with open-market sales totaling $493K (CFO Abernethy sold 2,311 shares for $363K; another officer sold 826 shares for $130K) plus non-cash tax-withholding surrenders by the CEO and CFO (~$1.1M combined, $0 economic value) and a director grant. Total open-market sales of $493K represent ~0.003% of NBIX's $16.0B market cap, trivial and routine. Sales are liquidity/vesting-driven (tax withholding, small sizes), not informational. No material directional signal.
NBIX drugs
NBIX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 16 $149.50entry
- T+1 · 2mo ago +1.56%α +0.42% · $151.83
- T+5 · 8w ago −6.70%α −9.26% · $139.49
- T+20 · 5w ago −9.09%α −11.15% · $135.91
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Insider cluster shows 2 insiders with open-market sales totaling $493K (CFO Abernethy sold 2,311 shares for $363K; another officer sold 826 shares for $130K) plus non-cash tax-withholding surrenders by the CEO and CFO (~$1.1M combined, $0 economic value) and a director grant. Total open-market sales of $493K represent ~0.003% of NBIX's $16.0B market cap, trivial and routine. Sales are liquidity/vesting-driven (tax withholding, small sizes), not informational. No material directional signal.
Key Financial Metrics
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NBIX-1789506185700 |
Track record
30 reports on NBIX
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +27.40% at T+60 after the Apr 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $174.41 Now $165.31 −5.22% settles Dec 10
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $169.14 Now $165.31 −2.26% settles Dec 9
- Nov 2, 202614d ago Press Release Bullish 6/10 No price data
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $164.85 Now $165.31 +0.28% settles Dec 2
- Oct 30, 202617d ago 144 Neutral 1/10 Entry $145.35 Now $165.31 +13.73% settles Dec 1
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $146.10 Now $165.31 +13.15% settles Nov 30
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $145.53 Now $165.31 +13.59% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers